Optimising care in COPD: managing co-existent bronchiectasis

To begin this episode of the Medical Insider COPD podcast, Dr Richard Russell is joined by Professor James Chalmers once more to delve into the topic of bronchiectasis. Specifically, they will be discussing how patients with bronchiectasis compare with patients with COPD, what treatments are the most appropriate and what the guidelines recommend. ^1–3 Dr Russell also presents a new publication looking into the impact of air pollution on the respiratory health of patients with COPD, ⁴ and highlights what patients have been talking about on social media this week, including vaccination and exercise programmes during the COVID-19 pandemic.

^1. Chalmers JD, et al. Am J Respir Crit Care Med 2018;197:1410–1420;
^2. Polverino E, et al. Eur Respir J 2017;50:1700629;
^3. Polverino E, et al. Eur Respir J 2018;51:1800328;
^4. Evangelopoulos D, et al. Eur Respir J 2021;58:2003432.

Disclosures
Professor James Chalmers
Professor James Chalmers has received consultancy fees from AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Grifols, Insmed, Janssen, Novartis and Zambon. He has also received research grant support from AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Gilead Sciences, Insmed and Novartis.

Bios:

Professor James Chalmers
Professor James Chalmers is the Asthma and Lung UK Chair of Respiratory Research at the University of Dundee, Scotland, and an Honorary consultant physician at Ninewells Hospital. His clinical and research interests are in difficult airways diseases, particularly bronchiectasis and COPD. He chaired the 2017 European Respiratory Society bronchiectasis guidelines, with 2020 Guidelines on inhaled corticosteroid use in COPD and the 2021 COVID-19 management guidelines. He is also deputy chief editor of the European Respiratory Journal.

This series of podcasts are intended for healthcare professionals only.

The Medical Insider COPD podcast series discusses hot topics in the world of COPD with those who know it best, aiming to spread information, debunk myths and improve the lives of patients. The Editorial Board of the Medical Insider COPD podcast is comprised of Professor James Chalmers, the British Lung Foundation Chair of Respiratory Research at the University of Dundee (UK), Professor Michael Dreher, the Head of the Department of Pneumology and Intensive Care Medicine at the University Hospital Aachen (Germany), and the host and moderator, Dr Richard Russell, a Consultant Chest Physician at Lymington New Forest Hospital (UK), a Senior Clinical Researcher at the University of Oxford (UK) and the founding editor of the International Journal of COPD. These series of podcasts have not been peer-reviewed, but have been vetted by the journal’s Editor-in-Chief.